We've gotta start fighting back!!!!! This Al Musella guy and his foundation are supposed to be unbiased in their presentations for all companies developing cancer treatments!! Last night, I watched Dr. Robert Aiken's presentation on the fledging company that he represents, AND who was an investigator for the NWBO Phase III Clinical trial AND who authored parts of the JAMA article that praised DCVax-L. Dr. Aiken said in an answer to a question about DCVax-L that "DCVax-L is a first generation Dendritic Cell technology unlike the future of cancer treatments arising from the 3rd and 4th generation mRNA dendritic cell technologies being developed by his company, Diaconis AND that unfortunately, DCVax-L will never see the light of day at the FDA." What the hell ??? His little fly by night company is barly in a Phase II trial and, even if successful after Phase II, won't be available until 2030!!!! In the first place, no one will use or trust mRNA because of the Covid fiasco and more importantly, patients need a personalized vaccine like DCVax-L that can identify all the specific antigens on each patients tumor. mRNA cannot do that !!! It misses antigens, anyone of which will kill that patient. Hell, it's like playing Russian Roulete!!
We know why Musella sponsors these kinds of liars, because Roche wants mRNA and ROCHE IS THE BIGGEST SINGLE CONTRIBUTOR TO THE MUSELLA FOUNDATION and guess what company is right up at the top with Roche.....Novocure!! In most cases, money talks and bullshit walks but in this case money talks and patients die. NWBO will be the Xerox of healthcare as it applizes all healthcare treatments.
Cheers,
BB
Market Data 
Markets 
